Search Results 1701-1710 of 16145 for chemoprevention
The purpose of this study is to determine the safety of VSV-IFNβ-NIS in combination with pembrolizumab, followed by expansion to examine effectiveness of ...
Stanko KM, Thomas A, Cullen MW, McCully RB, Schroeder DR, Kane GC, Pellikka PA, Mauck KF. Postoperative Outcomes After Delay or Cancellation of Noncardiac ...
I'm walking a fine line between jubilation and anxiety. As a two-time ovarian cancer survivor, I'm nearing the anniversary of my recurrence.
Anton Decker, president of Mayo Clinic International. And he emphasizes that sharing research and clinical expertise goes both ways. Mayo is learning from ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...
These findings were presented on Tuesday, Oct. 23, by Mayo Clinic researchers at the 2018 annual meeting of the American Society for Radiation Oncology (ASTRO) ...
The purpose of this study is to evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in ...
The purpose of this study is develop a tool called the Vestibular and Balance Function Measure (VBFM) to evaluate vertigo, dizziness, or balance problems that ...
About this study. The purpose of this study is to determine patient and manufacturing factors that influence orthobiologic agent (OBA) product components ...
Z-endoxifen, a potent derivative of the drug tamoxifen, could be a new treatment for the most common form of breast cancer in women with metastatic disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.